1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Mama>98.0% (HPLC) Brexpiprazole Intermediate Factory
Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-tasi CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3
Igoa Vailaau | 1-(1-Benzothiophen-4-yl) piperazine Hydrochloride |
Synonyms | Brexpiprazole Intermediate 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride |
Numera CAS | 913614-18-3 |
CAT Numera | RF-PI1034 |
Tulaga Fa'asoa | I Fa'atauga, Gaosiga Gafatia 100MT/Tausaga |
Fuafua mole | C12H15ClN2S |
Molecular Weight | 254.7789 |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e i le Pa'epa'e Pa'epa'e |
Fa'ailoaga | Taimi fa'atumauina o le fa'ata'ita'iga e fa'atatau i le tulaga fa'asino |
Mama / Suʻesuʻega Metotia | >99.0% (HPLC) |
Ma'imau ile Fa'amago | <0.50% |
Vai (KF) | <0.50% |
Toega i luga o le mumu | <0.20% |
Mea Fa'atatau | (HPLC) |
So'o se Fa'aleaga Ta'ito'atasi | <0.50% |
Aofa'i Fa'aleaga | <1.00% |
Alaleo Infrared | E tusa ai ma le Fauga |
Proton NMR Alaleo | E tusa ai ma le Fauga |
Tulaga Su'ega | Enterprise Standard |
Fa'aoga | Vaitaimi ole Brexpiprazole (CAS: 913611-97-9) |
afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu
1-(1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) o se vaeluaga ole Brexpiprazole (CAS: 913611-97-9).Brexpiprazole o se ituaiga atypical antipsychotic.O le dopamine D2 o le vaega ole agonist.I le avea ai ma se tala fou o le serotonin-dopamine, e mafai ona faʻaaogaina mo togafitiga o le schizophrenia, ma mo togafitiga faʻaopoopo mo le atuatuvale.E mafai foi ona maua ai le aoga ma le gafatia i luga o togafitiga faʻapipiʻi faʻapipiʻi mo le maʻi faʻavaivaia tele (MDD).O le vailaʻau o loʻo faʻaalia se talaaga faʻapitoa faʻafomaʻi, galue o se vaega o le agonist o le serotonin 5-HT1A ma le dopamine D2 faʻafeiloaʻi ma o se faʻataʻitaʻiga atoa o le 5-HT2A ma le noradrenaline α1B / 2C receptors, faʻatasi ai ma le tutusa o le subnanomolar binding affinity.O le vailaʻau, lea na atiaʻe e Otsuka ma Lundbeck, na faʻamaonia i le 2015 e le FDA mo togafitiga o le schizophrenia ma o se togafitiga faʻaopoopo mo le atuatuvale.